文献速递乳房整形与再造美容整形

乳腺癌保乳治疗的美容效果及延期重建选择

Breast-conserving therapy for breast cancer: Cosmetic results and options for delayed reconstruction.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2017-05-18

本研究由四名重建外科医生评估109例保乳治疗患者的美容效果,并判断延期重建适应证与首选术式。平均美容效果评为一般(2.7/4.0),乳房较大、肿瘤较大及腋窝淋巴结清扫是美容效果差的危险因素;同侧重建推荐率在美容效果好与差的患者中分别为55.6%和94.5%,但对重建术式的观察者间一致性较差。

要点

  • 保乳治疗后平均美容效果为一般(2.7/4.0)。
  • 乳房较大、肿瘤较大及腋窝淋巴结清扫与美容效果差相关。
  • 美容效果差者更常被推荐同侧重建,但术式选择一致性差。

核心结论

  • 保乳治疗后的美容效果受乳房大小、肿瘤大小和腋窝淋巴结清扫影响。
  • 虽有多种重建选项,但修正手术的最佳方法尚未确定,需未来研究制定循证指南。

研究设计与样本

  • 四名重建外科医生对109例保乳治疗患者的美容效果进行评估。
  • 外科医生同时判断患者是否适合延期重建及首选重建类型,并评价观察者间和观察者内一致性。

主要发现

  • 平均总体美容效果评为一般(2.7/4.0,SD 0.9,范围1.0-4.0)。
  • 美容效果差的危险因素包括乳房较大(OR 3.81,p=0.040)、肿瘤较大(OR 1.63,p=0.028)和腋窝淋巴结清扫(OR 3.09,p=0.013)。
  • 美容效果好与差的患者中,同侧重建推荐率分别为55.6%和94.5%,对侧重建推荐率分别为16.7%和73.3%。
  • 同侧最常报告皮瓣重建和脂肪填充,对侧最常报告乳房缩小,预期合理改善(2.2/4.0,SD 0.5,范围1.08-3.3)。
  • 美容效果观察者间一致性为0.5-0.7,观察者内一致性为0.63-0.79,为中等至良好;推荐重建技术的一致性较差(主要<0.50)。

临床怎么用

  • 评估保乳治疗患者美容效果时需关注乳房大小、肿瘤大小及是否行腋窝淋巴结清扫。
  • 对美容效果差的患者可考虑同侧皮瓣重建或脂肪填充,对侧可考虑乳房缩小。
  • 重建术式选择缺乏一致性,临床决策需个体化并待进一步证据。

局限性

  • 最佳修正手术方法尚未确定。
  • 推荐重建技术的一致性较差(主要<0.50)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Optimisation of the cosmetic outcome after breast-conserving therapy (BCT) is important. We aimed to determine the cosmetic outcome following BCT and factors influencing this cosmesis and identify the most favourable options for delayed breast reconstruction. MATERIALS AND METHODS: Four reconstructive surgeons evaluated the cosmetic outcome of 109 patients after BCT. Additionally, the surgeons indicated which patients were amenable for delayed reconstruction and the preferred type of reconstruction. The inter- and intra-observer agreement of the surgeons was rated. RESULTS: The mean overall cosmetic outcome was rated as fair (2.7/4.0, SD 0.9, 1.0-4.0). Risk factors for a poor cosmesis were larger breast size (OR 3.81, p = 0.040), larger tumour (OR 1.63, p = 0.028) and axillary lymph node dissection (ALND) (OR 3.09, p = 0.013). Reconstruction of the ipsilateral side was recommended in 55.6% and 94.5% and contralateral reconstruction in 16.7% and 73.3% of patients with good and poor cosmesis, respectively. Flap reconstruction and lipofilling were most commonly reported for the ipsilateral, and breast reduction for the contralateral breast, with reasonable improvement expected (2.2/4.0, SD 0.5, 1.08-3.3). The inter- (0.5-0.7) and intra-observer (0.63-0.79) agreement of the cosmesis was moderate to good, however, poor regarding the recommended reconstruction techniques (mainly < 0.50). CONCLUSION: Cosmetic outcome after BCT is influenced by breast and tumour size and ALND. Although several reconstructive options are available, the optimal method for revision surgery has not yet been determined. Future studies are necessary to obtain evidence-based guidelines for reconstructive surgery after BCT.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Negenborn VL, Volders JH, Krekel NMA, et al. Breast-conserving therapy for breast cancer: Cosmetic results and options for delayed reconstruction. J Plast Reconstr Aesthet Surg. 2017. PMID: 28610896. doi:10.1016/j.bjps.2017.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。